Search Results - Heigener DF
- Showing 1 - 1 results of 1
-
1
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer by Vergnenègre A, Ray JA, Chouaid C, Grossi F, Bischoff HG, Heigener DF, Walzer S
Published 2012Call Number: Loading…Connect to this object online.
Located: Loading…
Book